vs

Side-by-side financial comparison of Pathfinder Bancorp, Inc. (PBHC) and SUTRO BIOPHARMA, INC. (STRO). Click either name above to swap in a different company.

Pathfinder Bancorp, Inc. is the larger business by last-quarter revenue ($11.8M vs $11.6M, roughly 1.0× SUTRO BIOPHARMA, INC.). On growth, SUTRO BIOPHARMA, INC. posted the faster year-over-year revenue change (-21.4% vs -22.6%). Over the past eight quarters, Pathfinder Bancorp, Inc.'s revenue compounded faster (3.0% CAGR vs -5.4%).

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in Ja...

PBHC vs STRO — Head-to-Head

Bigger by revenue
PBHC
PBHC
1.0× larger
PBHC
$11.8M
$11.6M
STRO
Growing faster (revenue YoY)
STRO
STRO
+1.3% gap
STRO
-21.4%
-22.6%
PBHC
Faster 2-yr revenue CAGR
PBHC
PBHC
Annualised
PBHC
3.0%
-5.4%
STRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBHC
PBHC
STRO
STRO
Revenue
$11.8M
$11.6M
Net Profit
$-5.6M
Gross Margin
Operating Margin
-81.1%
Net Margin
-52.9%
Revenue YoY
-22.6%
-21.4%
Net Profit YoY
-242.4%
35.4%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBHC
PBHC
STRO
STRO
Q4 25
$11.8M
$11.6M
Q3 25
$13.1M
$9.7M
Q2 25
$9.3M
$63.7M
Q1 25
$12.6M
$17.4M
Q4 24
$15.3M
$14.8M
Q3 24
$13.4M
$8.5M
Q2 24
$10.7M
$25.7M
Q1 24
$11.1M
$13.0M
Net Profit
PBHC
PBHC
STRO
STRO
Q4 25
$-5.6M
Q3 25
$626.0K
$-56.9M
Q2 25
$31.0K
$-11.5M
Q1 25
$3.0M
$-76.0M
Q4 24
$3.9M
$-72.4M
Q3 24
$-4.6M
$-48.8M
Q2 24
$2.0M
$-48.0M
Q1 24
$2.1M
$-58.2M
Operating Margin
PBHC
PBHC
STRO
STRO
Q4 25
-81.1%
Q3 25
5.1%
-499.9%
Q2 25
0.4%
-5.2%
Q1 25
29.5%
-393.8%
Q4 24
55.4%
-440.7%
Q3 24
-43.1%
-797.2%
Q2 24
23.3%
-189.4%
Q1 24
24.3%
-435.0%
Net Margin
PBHC
PBHC
STRO
STRO
Q4 25
-52.9%
Q3 25
4.8%
-586.6%
Q2 25
0.3%
-18.0%
Q1 25
23.6%
-436.6%
Q4 24
37.7%
-489.2%
Q3 24
-34.6%
-572.6%
Q2 24
18.7%
-186.8%
Q1 24
19.0%
-447.5%
EPS (diluted)
PBHC
PBHC
STRO
STRO
Q4 25
Q3 25
$0.47
$-0.67
Q2 25
$0.47
$-0.14
Q1 25
$-0.91
Q4 24
$-27.63
Q3 24
$0.41
$-0.59
Q2 24
$0.41
$-0.59
Q1 24
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBHC
PBHC
STRO
STRO
Cash + ST InvestmentsLiquidity on hand
$141.4M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$122.5M
$-132.5M
Total Assets
$1.4B
$173.8M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBHC
PBHC
STRO
STRO
Q4 25
$141.4M
Q3 25
$167.6M
Q2 25
$205.1M
Q1 25
$249.0M
Q4 24
$316.9M
Q3 24
$388.3M
Q2 24
$375.6M
Q1 24
$267.6M
Total Debt
PBHC
PBHC
STRO
STRO
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
PBHC
PBHC
STRO
STRO
Q4 25
$122.5M
$-132.5M
Q3 25
$126.3M
$-87.3M
Q2 25
$124.4M
$-32.1M
Q1 25
$124.9M
$-25.8M
Q4 24
$121.5M
$44.6M
Q3 24
$120.2M
$111.2M
Q2 24
$123.3M
$152.2M
Q1 24
$121.8M
$98.0M
Total Assets
PBHC
PBHC
STRO
STRO
Q4 25
$1.4B
$173.8M
Q3 25
$1.5B
$209.7M
Q2 25
$1.5B
$262.4M
Q1 25
$1.5B
$321.4M
Q4 24
$1.5B
$387.2M
Q3 24
$1.5B
$451.8M
Q2 24
$1.4B
$489.0M
Q1 24
$1.5B
$403.4M
Debt / Equity
PBHC
PBHC
STRO
STRO
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBHC
PBHC
STRO
STRO
Operating Cash FlowLast quarter
$11.7M
$-177.2M
Free Cash FlowOCF − Capex
$10.4M
FCF MarginFCF / Revenue
88.1%
Capex IntensityCapex / Revenue
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBHC
PBHC
STRO
STRO
Q4 25
$11.7M
$-177.2M
Q3 25
$7.0M
$-38.2M
Q2 25
$-3.7M
$-44.7M
Q1 25
$5.7M
$-67.9M
Q4 24
$11.2M
$-71.7M
Q3 24
$11.8M
$-64.5M
Q2 24
$1.5M
$9.5M
Q1 24
$504.0K
$-64.7M
Free Cash Flow
PBHC
PBHC
STRO
STRO
Q4 25
$10.4M
Q3 25
$6.9M
Q2 25
$-4.0M
Q1 25
$5.1M
Q4 24
$9.1M
Q3 24
$11.3M
Q2 24
$637.0K
Q1 24
$274.0K
FCF Margin
PBHC
PBHC
STRO
STRO
Q4 25
88.1%
Q3 25
52.8%
Q2 25
-42.6%
Q1 25
40.1%
Q4 24
59.9%
Q3 24
84.3%
Q2 24
6.0%
Q1 24
2.5%
Capex Intensity
PBHC
PBHC
STRO
STRO
Q4 25
10.7%
Q3 25
1.0%
Q2 25
2.4%
Q1 25
5.1%
Q4 24
13.5%
Q3 24
3.8%
Q2 24
8.2%
Q1 24
2.1%
Cash Conversion
PBHC
PBHC
STRO
STRO
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

STRO
STRO

Segment breakdown not available.

Related Comparisons